NCT06335134View on ClinicalTrials.gov

A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

July 14, 2023

Primary Completion Date

January 8, 2024

Study Completion Date

June 28, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

XW003 injection

Administered subcutaneously

DRUG

Metformin

Administered orally

DRUG

Warfarin

Administered orally

DRUG

Rosuvastatin

Administered orally

DRUG

Digoxin

Administered orally

Trial Locations (1)

Unknown

West China Second University Hospital, Sichuan University, Chengdu

All Listed Sponsors
lead

Hangzhou Sciwind Biosciences Co., Ltd.

INDUSTRY